Puerarin prevents progression of experimental hypoxia-induced pulmonary hypertension via inhibition of autophagy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Puerarin prevents progression of experimental hypoxia-induced pulmonary hypertension via inhibition of autophagy

Published:2019-10 Issue:2 Volume:141 Page:97-105
ISSN:1347-8613
Container-title:Journal of Pharmacological Sciences
language:en
Short-container-title:Journal of Pharmacological Sciences

Author:

Zhang Xiaodan,Liu Qi,Zhang Chen,Sheng Jiejing,Li Songlin,Li Wendi,Yang Xinying,Wang Xiaoying,He Siyu,Bai June,Zhu Daling

Funder

Harbin Medical University

Heilongjiang Province Natural Science Foundation

Publisher

Elsevier BV

Subject

Pharmacology,Molecular Medicine

Reference33 articles.

1. The pathogenesis of pulmonary hypertension--an update;Huber;Swiss Med Wkly,2015

2. Methods in mammalian autophagy research;Mizushima;Cell,2010

3. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era;Humbert;Circulation,2010

4. The search for disease-modifying therapies in pulmonary hypertension;Woodcock;J Cardiovasc Pharmacol Ther,2019

5. Selenoprotein P promotes the development of pulmonary arterial hypertension;Kikuchi;Circulation,2018

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Puerarin Alleviates Blood Pressure via Inhibition of ROS/TLR4/NLRP3 Inflammasome Signaling Pathway in the Hypothalamic Paraventricular Nucleus of Salt-Induced Prehypertensive Rats;Nutrients;2024-08-06

2. Emerging connectivity of programmed cell death pathways and pulmonary vascular remodelling during pulmonary hypertension;Journal of Cellular and Molecular Medicine;2024-08

3. Therapeutic potential of natural flavonoids in pulmonary arterial hypertension: A review;Phytomedicine;2024-06

4. Activation of the p62‐Keap1‐Nrf2 pathway improves pulmonary arterial hypertension in MCT‐induced rats by inhibiting autophagy;The FASEB Journal;2024-02-03

5. Unleashing the Potential of Nrf2: A Novel Therapeutic Target for Pulmonary Vascular Remodeling;Antioxidants;2023-11-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3